Stryker will spend $1.41 billion to acquire Mako Surgical and all of its robotic assisted surgery technology. The medical device maker will pay $30 per Mako share, an 86 percent premium to its $16.17 closing price Tuesday. The companies put the deal's value at about $1.65 billion.
A team from the University of Texas at Arlington has used mathematical modeling to develop a computer simulation they hope will one day improve the treatment of dangerous reactions to medical implants such as stents, catheters and artificial joints.
In the field of medical technology, wireless devices are seeing some of the most broad-reaching growth. This is due mostly in part to the wide range of applications that wireless medicine encompasses. Mobi Health News reports that the top ten areas wireless medicine has directly benefited include: Alzheimer’s, asthma, breast cancer, COPD, depression, diabetes, heart failure, hypertension, obesity, and sleep disorders.
The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.
Integra LifeSciences Holdings Corporation today announced the first implantation of its Integra Titan Reverse Shoulder System, in the United States. The system, which is used in the treatment of shoulder replacement surgery, was implanted by William Geissler, M.D., Professor of Orthopaedic Surgery at the University of Mississippi Medical Center.
A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years. The technology is currently being refined and tested at the University of Southampton with support from the Engineering and Physical Sciences Research Council (EPSRC).
Wendy Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that two new videos have been posted on YouTube addressing common concerns and questions asked by hip replacement patients who received notice of the recall of their Stryker Rejuvenate or Stryker ABG II hip implant.
Researchers from Graz University of Technology, together with colleagues from the Medical University of Graz, Vienna University of Technology and the University of Natural Resources and Life Sciences, Vienna, have managed to develop absorbable implants to promote bone healing which are broken down by the body.
Patients who continue to suffer inconvenience after a healed bone fracture may be better off having any plates, pins and screws removed. Scientific research headed by Dagmar Vos, who took her doctoral degree at University Medical Center (UMC) Utrecht on 17 September, demonstrates that most complaints and symptoms, such as pain and restricted motion, improve after removing these so-called osteosynthesis materials.
Researchers using the cutting-edge X-ray technology at the U.S. Department of Energy’s Advanced Photon Source were able to take an inside look at several insects, gathering results that go beyond learning about insect physiology and biology. What they found could provide a blueprint for a material used for artificial ligaments and a new insight on how human muscles function.
On Tuesday, September 17, JoVE, the Journal of Visualized Experiments, will publish a novel technique for imaging muscle function while in motion. Research in this area could uncover the root of musculoskeletal disorders, such as the development of osteoarthritis following ACL surgery.
Regentis Biomaterials announced today new clinical data demonstrating the efficacy and safety of its GelrinC implant for treating articular cartilage in injured knees. As presented at the International Cartilage Repair Society World Congress in Izmir, Turkey, the clinical results demonstrated sustained knee function improvement over 24 months after implantation and significant pain reduction.
Spinal injuries are present in 1 out of 9 U.S. military personnel sustaining combat injuries in Iraq or Afghanistan -- a much higher rate than in previous wars, according to a report in the Sept. 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Through significant investments in research and development, OMAX Corporation has made great strides in micro-abrasive waterjet technology, targeting manufacturers that produce parts or part features smaller than 300 microns. The company will spotlight some of its recent micromachining achievements...
DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announced the launch of new instrumentation that enables less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB™ System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.
Smith & Nephew wants a federal judge in California to toss a lawsuit filed by a doctor who blames a botched hip implantation on the British medical device company. Dr. David Chao sued Smith & Nephew in the U.S. District Court for Southern California, alleging that inadequate training and faulty surgical scissors for SNN's Birmingham Hip Resurfacing implant led to the botched surgery on Kathleen Adams in 2007.
Tyber Medical, a privately held medical device company focused on developing innovative spine and orthopaedic devices for private label opportunities, announces CE Mark approval for TyPEEK, a proprietary titanium plasma sprayed PEEK interbody system.
Consumers Union is pushing device makers to equip patients with warranties so they will have a better understanding of how long an implant is expected to last and a clear process to follow in the event that it fails prematurely. Ultimately, warranties will encourage companies to make their devices safer and more durable, according to Consumers Union.
Moirai Orthopaedics, L.L.C., a Metairie, Louisiana based orthopaedic implant development company, is pleased to announce it has received CE mark approval for its new Pyrocarbon Implant Replacement (PIR) System. The PIR System, developed in conjunction with the not-for-profit Fellowship of Orthopaedic Researchers, is intended to treat patients with focal chondral and osteochondral defects of the medial femoral condyle of the knee.
In a draft guidance document, FDA has placed its summary of ideas regarding biocompatibility and possible changes that could eventually replace FDA G-95 Blue Book Memorandum #G95-1 on biocompatibility. The draft document has been out since April and is widely available, though it has not been formally released.
The lightweight skeletons of organisms such as sea sponges display a strength that far exceeds that of manmade products constructed from similar materials. Scientists have long suspected that the difference has to do with the hierarchical architecture of the biological materials...
California spinal devices maker NuVasive Inc. has recently gotten very popular with law firms, which began piling onto a class action lawsuit following the revelation that the company is under investigation by the Health & Human Services Dept.'s Office of the Inspector General.
A new ASTM International standard will provide a consistent method for analyzing hip stems used in hip replacement surgery. The new standard, ASTM F2996, Practice for Finite Element Analysis (FEA) of Nonmodular Metallic Orthopaedic Hip Femoral Stems, was developed by Subcommittee F04.22 on Arthroplasty, part of ASTM International Committee F04 on Medical and Surgical Materials and Devices.
While the use of disposables in healthcare is certainly nothing new, their implementation as instrumentation in orthopedic procedures is. “Disposables in the O.R.” takes a look at the benefits of this trend.
The European market for orthopedic biomaterials saw a decline between 2010 and 2012 due to a period of economic uncertainty and severe budgetary restrictions. However, this rate of decline has been diminishing, a promising sign for future growth.